New Multiple Myeloma Drug JS-K Making its Way Through the Drug Development Process

The Hopeful Future of Multiple Myeloma in 2016 with Dr. Kenneth Anderson, MD, PhD, Dana Farber Cancer Institute

An Incredible Year for Multiple Myeloma. Highlights with Dr. Robert Orlowski, MD, PhD, MD Anderson

Important Steps for Dealing with High Risk Multiple Myeloma with Dr. Guido Tricot, MD, PhD, University of Iowa

Exciting Myeloma Announcements and What to Watch For at ASH 2015 with Dr. Ola Landgren, MD, PhD, MSKCC

Hitting Both the Surface and Interior of Multiple Myeloma cells Using New Immunotherapies with Dr. Djordje Atanackovic, MD

Lessons Learned from CAR19 and Next Steps at UPENN for CAR T Cell Research in Multiple Myeloma, with Dr. Adam Cohen, MD

The Ever Expanding Multiple Myeloma Immune Therapy Aresenal with Dr. Don Benson, MD, PhD, Ohio State University

Low-to-no-chemo allo myeloma transplant and immune therapy with auto transplant with Dr. Daniel Fowler, MD, NIH